Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Inclusive experimental design is essential to evidence-based science, requiring diverse resources to consider factors, such as age, race, ethnicity and gender. Accounting for inclusion and diversity can fuel advances in bioengineering that are central to biomedical research and to closing gaps in scientific knowledge. See Amy Hinterberger
Policies that limit diversity and inclusion undermine evidence-based science by creating gaps in the data, potentially distorting findings and skewing results. When diversity and inclusion are sidelined, scientific progress is hindered.
The development of representative and reliable cellular models requires researchers to prioritize inclusivity and reconsider how to approach differences.
Bioengineering advances and genome-editing technologies can drive the development of a bio-based circular plastic economy to address the plastic crisis.
The incipient use of microphysiological systems (MPSs) in the drug regulatory pathway is based on equivalent or superior predictive value in the evaluation of drug efficacy, safety and toxicology, compared with other novel alternative methods (NAMs) or animal studies. Current MPS practice is not deploying available physiological culture media solutions. Will the clinical translational reliability of MPSs be potentially compromised by the use of hyper-nutritional media?
An article in Nature Materials reports a topological acoustofluidic device that enables the control of sound waves, fluid flow and particles at the micro- and nanoscales, all on a single chip.
Extracellular vesicles can be designed to serve as delivery platforms for gene therapy. This Review discusses the application and engineering of extracellular vesicles for different gene-therapy modalities, outlining crucial steps to advance this technology into the clinic.
Enhancers are genomic elements critical for regulating gene expression. In this Review, the authors discuss how sequence-to-function models can be used to unravel the rules underlying enhancer activity and function as biological ‘oracles’ aiding the design of synthetic enhancers with tailored cell-type-specific or cell-state-specific activities.
Personalized bioengineered implant scaffolds offer customizable medical solutions for tissue and organ regeneration. This Review provides a framework for navigating the regulatory process and addressing challenges in technical development and biofabrication to ensure clinical translation of personalized devices.
Vibration can be applied to cells in vitro and in vivo to trigger specific mechanotransductive pathways and guide cell-fate decisions. This Review explores the use of vibrational stimulation for cell engineering, outlining key pathways, devices and applications for this new mechanical cell-stimulation tool.